<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width,initial-scale=1" />
    <title>Patient Profile â€” Page 6</title>

    <link
      href="https://fonts.googleapis.com/css2?family=Montserrat:wght@600;700;800&family=Poppins:wght@400;600&display=swap"
      rel="stylesheet"
    />
    <link
      rel="stylesheet"
      href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.4/css/all.min.css"
      integrity="sha512-1ycn6IcaQQ40/MKBW2W4Rhis/DbILU74C1vSrLJxCq57o941Ym01SwNsOMqvEBFlcgUa6xLiPY/NS5R+E6ztJQ=="
      crossorigin="anonymous"
      referrerpolicy="no-referrer"
    />

    <link rel="stylesheet" href="4.css" />
  </head>
  <body>
    <div class="page-wrap">
      <header class="top-logos">
        <img src="assets/RSSDI.png" alt="left-logo" class="logo-left" />
        <img src="assets/zydus.png" alt="right-logo" class="logo-right" />
      </header>

      <main class="hero">
        <div class="banner">
          <span>MASTER THE REAL WORLD CHALLENGE</span>
        </div>

        <div class="profile-card-wrap">
          <div class="profile-content">
            <div class="profile-header">
              <img
                src="icon/2.png"
                alt="Profile Icon"
                class="profile-icon"
              />
              <h1 class="profile-title">
                Obese, NAFLD & dyslipidaemia in non-diabetic <br> patient
              </h1>
            </div>

            <div class="quiz-section">
              <div class="quiz-question">
                <strong>3.</strong> Given this patient profile, what is the most appropriate next step in managing metabolic dysfunction?
              </div>

              <div class="quiz-options">
                <div class="option-item">
                  <input type="radio" id="optA" name="quiz1" value="A" />
                  <label for="optA">
                    <span class="radio-style"></span>
                    <strong>A)</strong> Start Semaglutide to improve weight and liver parameters
                  </label>
                </div>
                <div class="option-item">
                  <input type="radio" id="optB" name="quiz1" value="B" />
                  <label for="optB">
                    <span class="radio-style"></span>
                    <strong>B)</strong> Continue lifestyle and pharmacotherapy with Saroglitazar 4 mg
                  </label>
                </div>
                <div class="option-item">
                  <input type="radio" id="optC" name="quiz1" value="C" />
                  <label for="optC">
                    <span class="radio-style"></span>
                    <strong>C)</strong> Start pioglitazone for better fibrosis reduction
                  </label>
                </div>
                <div class="option-item">
                  <input type="radio" id="optD" name="quiz1" value="D" />
                  <label for="optD">
                    <span class="radio-style"></span>
                    <strong>D)</strong> Add fenofibrate to control triglycerides
                  </label>
                </div>
                <div class="option-item">
                  <input type="radio" id="optD" name="quiz1" value="D" />
                  <label for="optD">
                    <span class="radio-style"></span>
                    <strong>E)</strong> Refer for surgical weight reduction
                  </label>
                </div>
              </div>

              <div class="quiz-controls">
                <div id="quizError" class="quiz-error-msg">
                  Please select an option first
                </div>
                <button id="submitBtn" class="quiz-next-btn">Submit</button>
              </div>

              <div class="correct-answer">
                <i class="fas fa-check-square"></i>
                Correct answer: B) Continue lifestyle and pharmacotherapy with Saroglitazar 4 mg.
              </div>

              <div class="rationale-box">
                <strong>Rationale:</strong> The patient has both dyslipidaemia and fatty liver. Currently, Saroglitazar is the only approved therapy for MASLD and non-cirrhotic MASH in India. Saroglitazar offers targeted benefits by reducing triglycerides, improving HDL, and reversing hepatic inflammation and fibrosis along with lifestyle modification, for ongoing metabolic control.
              </div>

              <div class="quiz-final-controls">
                <button id="finalNextBtn" class="quiz-next-btn" onclick="window.location.href='7_2.html'">Next</button>
              </div>
            </div>
            </div>
        </div>
        <img
          src="assets/Lipaglyn.png"
          alt="bottom-liver-logo"
          class="logo-lipaglyn"
        />
      </main>

      <div class="profile-illustration">
        <img
          src="assets/illustration.png"
          alt="Doctor Illustration"
          class="doctor-img"
        />
      </div>
    </div>

    <script src="4.js"></script>
  </body>
</html>